Shyamakant Giri to take over as Gland Pharma CEO in January 2025
Gland Pharma on Friday said its board has appointed Shyamakant Giri as CEO with effect from January 15, 2025.
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals, responsible for the commercial expansion and growth in India and Rest of the World markets.
Srinivas Sadu will continue to be the executive chairman of the company and support its next phase of growth, Gland Pharma said.
ALSO READ: DBS Bank CEO Piyush Gupta to depart in March 2025; Tan Su Shan to succeed
